Ignite Creation Date:
2024-05-06 @ 6:20 PM
Last Modification Date:
2024-10-26 @ 2:46 PM
Study NCT ID:
NCT05627245
Status:
RECRUITING
Last Update Posted:
2024-07-03
First Post:
2022-11-23
Brief Title:
Testing the Safety of the Anti-cancer Drugs Tazemetostat and Belinostat in Patients With Lymphomas That Have Resisted Treatment
Sponsor:
Organization:
National Cancer Institute NCI